Alector launches XIGDUO
Date: 16 Sep 2016Alector has introduced the AstraZeneca antidiabetic Xigduo, a fixed combination of dapagliflozin and metformin, for adult patients with Type 2 diabetes who are inadequately controlled by metformin alone.
Alector has introduced the AstraZeneca antidiabetic Xigduo, a fixed combination of dapagliflozin and metformin, for adult patients with Type 2 diabetes who are inadequately controlled by metformin alone.